Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese.

BMC immunology - 8 May 2013

Lim Yun-Ping, Hsu Yu-An, Tsai Kun-Hsi, Tsai Fuu-Jen, Peng Cheng-Yuan, Liao Wen-Ling, Hung Dong-Zong, Tien Ni, Lin Chien-Yih, Wan Lei

Abstract excerpt

Genetic polymorphisms observed in various disease states associated with sensitivity or resistance to specific treatments have been a robust area of investigation for decades, with the potential to allow clinicians to make evidence-based decisions on the appropriate course of treatment. This study aimed to evaluate whether genetic polymorphisms of the signal transducer and activator of transcription 6 gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Multivariate Analysis

Share to Polyethylene Glycols

Share to Ribavirin

Share to STAT6 Transcription Factor

Share to Taiwan

Source

Open in PubMed Open full text

Identifiers

PMID: 23651608
DOI: 10.1186/1471-2172-14-21
PMCID: PMC3654984

Genes

STAT6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese.PMID 23651608Read ↗

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment.Semantic proximity Read ↗

Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis C.Semantic proximity Read ↗

Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B.Semantic proximity Read ↗

Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.Semantic proximity Read ↗

The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients.Semantic proximity Read ↗

Genetic influence of IFN-γ gene polymorphisms on hepatitis C progression and recovery.Semantic proximity Read ↗

Association between IFNL4 rs368234815 polymorphism and sustained virological response in chronic hepatitis C patients undergoing PEGylated interferon/ribavirin therapy: A meta-analysis.Semantic proximity Read ↗

Genetic variation in NOS2A is associated with a sustained virological response to peginterferon plus ribavirin therapy for chronic hepatitis C in Taiwanese Chinese.Semantic proximity Read ↗

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.Semantic proximity Read ↗

ZNF350 gene polymorphisms promote the response to Peg-IFNα therapy through JAK-STAT signaling pathway in patients with chronic hepatitis B.Semantic proximity Read ↗

The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.